This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion

Volume: 18, Issue: 4, Pages: 812 - 822
Published: Mar 14, 2019
Abstract
The combination of bevacizumab with temozolomide and radiotherapy was shown to prolong progression-free survival in newly diagnosed patients with glioblastoma, and this emphasizes the potential of bevacizumab as a glioma treatment. However, although bevacizumab effectively inhibits angiogenesis, it has also been reported to induce invasive proliferation. This study examined gene expression in glioma cells to investigate the mechanisms of...
Paper Details
Title
δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion
Published Date
Mar 14, 2019
Volume
18
Issue
4
Pages
812 - 822
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.